Life Sciences,
Journal Year:
2022,
Volume and Issue:
310, P. 121116 - 121116
Published: Oct. 24, 2022
We
have
previously
reported
that
advanced
glycation
end
products
derived
from
incubation
of
albumin
with
glycolaldehyde
(glycol-AGE),
lead
to
suppression
the
toll-like
receptor
4
(TLR4)
signaling
response
lipopolysaccharide.
Glycol-AGE-induced
TLR4
is
involved
in
downregulation
CD14,
which
an
adaptor
protein
necessary
for
transferring
lipopolysaccharide
TLR4.
Therefore,
glycol-AGEs
impair
innate
immune
through
upstream
process
signaling.
However,
effect
on
intracellular
related
remains
unclear.
This
study
aimed
examined
stimulator
interferon
gene
(STING)
macrophages.In
differentiated
THP-1
cells,
are
a
human
monocytic
leukemia
cell
line,
cyclic
GMP-AMP
(cGAMP)
transfection
was
used
activate
STING
The
phosphorylation
levels
TANK-binding
kinase
1
(TBK1)/interferon
regulatory
transcription
factor
3
(IRF3)
were
evaluated
by
western
blot
analysis.
Downstream
cytokine
quantitative
real-time
polymerase
chain
reaction
and
enzyme-linked
immunosorbent
assays.Glycol-AGEs
suppressed
cGAMP-induced
TBK1
IRF3,
as
well
production
cytokines
regulated
IRF3.
There
no
efficacy
cGAMP
transfection.
Treatment
neutralizing
antibody
against
CD36
prevented
also
upregulation
interferon-β
C-X-C
motif
chemokine
ligand
10
glycol-AGE-treated
cells.Glycol-AGEs
negatively
regulate
activation
STING/TBK1/IRF3
via
CD36.
Our
findings
suggest
impairment
suppressing
A
cytokine
storm
is
marked
by
excessive
pro-inflammatory
release,
and
has
emerged
as
a
key
factor
in
severe
COVID-19
cases
-
making
it
critical
therapeutic
target.
However,
its
pathophysiology
was
poorly
understood,
which
hindered
effective
treatment.
SARS-CoV-2
initially
disrupts
angiotensin
signalling,
promoting
inflammation
through
ACE-2
downregulation.
Some
patients'
immune
systems
then
fail
to
shift
from
innate
adaptive
immunity,
suppressing
interferon
responses
leading
pyroptosis
neutrophil
activation.
This
amplifies
tissue
damage
inflammation,
creating
loop.
The
result
the
disruption
of
Th1/Th2
Th17/Treg
balances,
lymphocyte
exhaustion,
extensive
blood
clotting.
Cytokine
treatments
include
glucocorticoids
suppress
system,
monoclonal
antibodies
neutralize
specific
cytokines,
JAK
inhibitors
block
receptor
signalling.
most
treatment
options
for
mitigating
infection
remain
vaccines
preventive
measure
antiviral
drugs
early
stages
infection.
article
synthesizes
insights
into
dysregulation
COVID-19,
offering
framework
better
understand
storms
improve
monitoring,
biomarker
discovery,
strategies
other
conditions
involving
storms.
Cellular and Molecular Immunology,
Journal Year:
2023,
Volume and Issue:
20(7), P. 835 - 849
Published: May 30, 2023
Abstract
Early
and
strong
interferon
type
I
(IFN-I)
responses
are
usually
associated
with
mild
COVID-19
disease,
whereas
persistent
or
unregulated
proinflammatory
cytokine
severe
disease
outcomes.
Previous
work
suggested
that
monocyte-derived
macrophages
(MDMs)
resistant
unresponsive
to
SARS-CoV-2
infection.
Here,
we
demonstrate
upon
phagocytosis
of
SARS-CoV-2-infected
cells,
MDMs
activated
secrete
IL-6
TNF.
Importantly,
in
turn
mediate
activation
plasmacytoid
dendritic
cells
(pDCs),
leading
the
secretion
high
levels
IFN-α
Furthermore,
pDC
promoted
production
by
MDMs.
This
kind
was
dependent
on
direct
integrin-mediated
cell‒cell
contacts
involved
stimulation
TLR7
STING
signaling
pathways.
Overall,
present
study
describes
a
novel
potent
pathway
is
linked
macrophage-mediated
clearance
infected
cells.
These
findings
suggest
infection
rate
may
lead
exaggerated
responses,
which
contribute
tissue
damage
disease.
Journal of Clinical Investigation,
Journal Year:
2024,
Volume and Issue:
134(9)
Published: April 30, 2024
BACKGROUNDPatients
hospitalized
for
COVID-19
exhibit
diverse
clinical
outcomes,
with
outcomes
some
individuals
diverging
over
time
even
though
their
initial
disease
severity
appears
similar
to
that
of
other
patients.
A
systematic
evaluation
molecular
and
cellular
profiles
the
full
course
can
link
immune
programs
coordination
progression
heterogeneity.METHODSWe
performed
deep
immunophenotyping
conducted
longitudinal
multiomics
modeling,
integrating
10
assays
1,152
Immunophenotyping
Assessment
in
a
Cohort
(IMPACC)
study
participants
identifying
several
cascades
were
significant
drivers
differential
outcomes.RESULTSIncreasing
was
driven
by
temporal
pattern
began
early
upregulation
immunosuppressive
metabolites
then
elevated
levels
inflammatory
cytokines,
signatures
coagulation,
formation
neutrophil
extracellular
traps,
T
cell
functional
dysregulation.
second
cascade,
predictive
28-day
mortality
among
critically
ill
patients,
characterized
reduced
total
plasma
Igs
B
cells
dysregulated
IFN
responsiveness.
We
demonstrated
balance
disruption
between
IFN-stimulated
genes
inhibitors
is
crucial
biomarker
mortality,
potentially
contributing
failure
viral
clearance
patients
fatal
illness.CONCLUSIONOur
profiling
revealed
across
omics
explain
progression,
providing
insights
inform
targeted
development
therapies
COVID-19,
especially
those
who
are
ill.TRIAL
REGISTRATIONClinicalTrials.gov
NCT04378777.FUNDINGNIH
(5R01AI135803-03,
5U19AI118608-04,
5U19AI128910-04,
4U19AI090023-11,
4U19AI118610-06,
R01AI145835-01A1S1,
5U19AI062629-17,
5U19AI057229-17,
5U19AI125357-05,
5U19AI128913-03,
3U19AI077439-13,
5U54AI142766-03,
5R01AI104870-07,
3U19AI089992-09,
3U19AI128913-03,
5T32DA018926-18);
NIAID,
NIH
(3U19AI1289130,
U19AI128913-04S1,
R01AI122220);
National
Science
Foundation
(DMS2310836).
Frontiers in Cardiovascular Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: April 11, 2024
Interferons
(IFNs)
and
IFN-related
pathways
play
key
roles
in
the
defence
against
microbial
infection.
However,
these
processes
may
also
be
activated
during
pathogenesis
of
non-infectious
diseases,
where
they
contribute
to
organ
injury,
or
function
a
compensatory
manner.
In
this
review,
we
explore
IFNs
heart
disease.
We
consider
cardiac
effects
type
I
IFN-stimulated
genes
(ISGs);
emerging
role
cyclic
GMP-AMP
synthase
(cGAS)-stimulator
interferon
(STING)
pathway;
seemingly
paradoxical
II
IFN,
IFN-γ;
varied
actions
regulatory
factor
(IRF)
family
transcription
factors.
Recombinant
small
molecule
inhibitors
mediators
IFN
receptor
signaling
are
already
employed
clinic
for
treatment
some
autoimmune
infections,
cancers.
There
has
been
renewed
interest
because
their
involvement
SARS-CoV-2
infection,
relatively
recent
emergence
cGAS-STING
as
pattern
recognition
receptor-activated
pathway.
Whether
advances
will
ultimately
result
improvements
care
those
experiencing
disease
remains
determined.
Frontiers in Neuroscience,
Journal Year:
2023,
Volume and Issue:
17
Published: Sept. 28, 2023
Approximately
one
third
of
non-hospitalized
coronavirus
disease
2019
(COVID-19)
patients
report
chronic
symptoms
after
recovering
from
the
acute
stage
severe
respiratory
syndrome
2
(SARS-CoV-2)
infection.
Some
most
persistent
and
common
complaints
this
post-acute
COVID-19
(PACS)
are
cognitive
in
nature,
described
subjectively
as
“brain
fog”
also
objectively
measured
deficits
executive
function,
working
memory,
attention,
processing
speed.
The
mechanisms
these
sequelae
currently
not
understood.
SARS-CoV-2
inflicts
damage
to
cerebral
blood
vessels
intestinal
wall
by
binding
angiotensin-converting
enzyme
(ACE2)
receptors
evoking
production
high
levels
systemic
cytokines,
compromising
brain’s
neurovascular
unit,
degrading
barrier,
potentially
increasing
permeability
both
harmful
substances.
Such
substances
hypothesized
be
produced
gut
pathogenic
microbiota
that,
given
profound
effects
has
on
gastrointestinal
system,
may
fourish
a
result
post-COVID-19
dysbiosis.
therefore
create
scenario
which
neurotoxic
neuroinflammatory
readily
proliferate
lumen
encounter
weakened
gaining
access
brain
subsequently
producing
deficits.
Here,
we
review
proposed
PACS
pathogenesis
along
gut-brain
axis,
while
identifying
specific
methodologies
that
available
experimentally
measure
each
individual
component
model.
Cellular and Molecular Life Sciences,
Journal Year:
2023,
Volume and Issue:
80(7)
Published: June 22, 2023
To
understand
in
detail
the
transcriptional
and
functional
overlap
of
IFN-I-
IFN-II-activated
responses,
we
used
an
integrative
RNAseq-ChIPseq
approach
Huh7.5
cells
characterized
genome-wide
role
pSTAT1,
pSTAT2,
IRF9
IRF1
time-dependent
ISG
expression.
For
first
time,
our
results
provide
detailed
insight
timely
steps
IFNα-
IFNγ-induced
transcription,
which
pSTAT1-
pSTAT2-containing
ISGF3
GAF-like
complexes
are
recruited
to
individual
or
combined
ISRE
GAS
composite
sites
a
phosphorylation-
manner.
Interestingly,
genes
displayed
more
heterogeneous
expression
pattern,
as
compared
(early)
(late),
with
time-
phosphorylation-dependent
recruitment
GAF,
after
IFNα
stimulation
GAF
IFNγ.
Moreover,
shared
features
through
transcription
factor
co-binding
closely
located
sites,
were
able
sustain
IFN
responsiveness
STAT1-,
STAT2-,
IRF9-,
IRF1-
IRF9/IRF1-mutant
Wt
cells.
Thus,
+
site
acted
molecular
switch,
depending
on
available
components
complexes.
Consequently,
STAT1,
STAT2
identified
that
part
positive
feedback
loop
controlling
long-term
IFNγ
responses.
More
important,
absence
any
one
components,
regulation
appeared
be
preserved.
Together,
these
findings
further
existence
novel
composite-dependent
intracellular
amplifier
circuit
prolonging
cellular
different
types
IFNs
subsequent
antiviral
activity.
It
also
offers
explanation
for
existing
between
Life,
Journal Year:
2023,
Volume and Issue:
13(11), P. 2121 - 2121
Published: Oct. 26, 2023
The
COVID-19
pandemic
has
affected
the
world
unprecedentedly,
with
both
positive
and
negative
impacts.
significantly
impacted
immune
system,
understanding
immunological
consequences
of
is
essential
for
developing
effective
treatment
strategies.
purpose
this
review
to
comprehensively
explore
provide
insights
into
aspects
long
COVID-19,
a
phenomenon
where
individuals
continue
experience
range
symptoms
complications,
even
after
acute
phase
infection
subsided.
system
responds
initial
by
producing
various
cells
molecules,
including
antibodies,
T
cells,
cytokines.
However,
in
some
patients,
response
becomes
dysregulated,
leading
chronic
inflammation
persistent
symptoms.
Long
encompasses
diverse
affecting
multiple
organ
systems,
respiratory,
cardiovascular,
neurological,
gastrointestinal
systems.
In
post-COVID-19
era,
its
impact
on
have
become
significant
concern.
Post-COVID-19
pathology,
autoimmunity
immune-mediated
disorders,
also
been
reported
patients.
This
provides
an
overview
current
relationship
responses,
pathology
patient
outcomes.
Additionally,
addresses
potential
treatments
immunomodulatory
therapies,
rehabilitation
programs,
mental
health
support,
all
which
aim
improve
quality
life
COVID-19.
Understanding
complex
interplay
between
crucial
targeted
therapeutic
strategies
providing
optimal
care
era.
Antibodies,
Journal Year:
2024,
Volume and Issue:
13(1), P. 13 - 13
Published: Feb. 8, 2024
The
COVID-19
pandemic
caused
by
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2)
has
led
to
almost
seven
million
deaths
worldwide.
SARS-CoV-2
causes
infection
through
respiratory
transmission
and
can
occur
either
without
any
symptoms
or
with
clinical
manifestations
which
be
mild,
severe
or,
in
some
cases,
even
fatal.
Innate
immunity
provides
the
initial
defense
against
virus
sensing
pathogen-associated
molecular
patterns
triggering
signaling
pathways
that
activate
antiviral
inflammatory
responses,
limit
viral
replication
help
identification
removal
of
infected
cells.
However,
temporally
dysregulated
excessive
activation
innate
immune
response
is
deleterious
for
host
associates
COVID-19.
In
addition
its
defensive
role,
pivotal
priming
adaptive
polarizing
effector
function.
This
capacity
relevant
context
both
natural
vaccination.
Here,
we
provide
an
overview
current
knowledge
responses
Deleted Journal,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 26, 2024
Corona
Virus
Disease
2019
(COVID-19)
has
brought
the
new
challenges
to
scientific
research.
Isodon
suzhouensis
good
anti-inflammatory
and
antioxidant
stress
effects,
which
is
considered
as
a
potential
treatment
for
COVID-19.
The
possibility
of
COVID-19
with
suzhouensis
and
its
mechanism
action
were
explored
by
employing
molecular
docking
network
pharmacology.
Network
pharmacology
used
screen
drug
targets,
Lipopolysaccharide
(LPS)
induced
RAW264.7
NR8383
cells
inflammation
model
was
experimental
verification.
Collectively
total
209
possible
linkages
against
18
chemical
components
from
suzhouensis
1194
related
targets
selected.
Among
these,
164
common
obtained
intersection
GO
KEGG
enriched
582
function
87
target
proteins
pathways,
respectively.
results
studies
revealed
that
rutin,
vitexin,
isoquercitrin
quercetin
had
significant
binding
ability
SARS-CoV-23CLpro
ACE2.
In
vitro
showed
extract
(ISE)
may
inhibit
activation
PI3K/Akt
pathway
expression
level
downstream
pro-inflammatory
factors
inhibiting
EGFR
in
LPS.
addition,
ISE
able
TLR4/NF-κB
signaling
exposed
Overall,
conclude
active
have
strong
therapeutic
through
multi-target,
multi-pathway
dimensions
can
be
promising
candidate
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: June 9, 2023
Detection
of
secretory
antibodies
in
the
airway
is
highly
desirable
when
evaluating
mucosal
protection
by
vaccines
against
a
respiratory
virus,
such
as
severe
acute
syndrome
coronavirus
2
(SARS-CoV-2).
We
show
that
intranasal
delivery
an
attenuated
SARS-CoV-2
(Nsp1-K164A/H165A)
induces
both
and
systemic
IgA
IgG
male
Syrian
hamsters.
Interestingly,
either
direct
immunization
or
airborne
transmission-mediated
Nsp1-K164A/H165A
hamsters
offers
heterologous
challenge
with
variants
concern
(VOCs)
including
Delta,
Omicron
BA.1,
BA.2.12.1
BA.5.
Vaccinated
animals
significant
reduction
tissue
viral
loads
lung
inflammation.
Similarly
viruses
bearing
BA.1
BA.5
spike
boost
variant-specific
neutralizing
mice
were
first
vaccinated
modified
vaccinia
virus
Ankara
vectors
(MVA)
expressing
full-length
WA1/2020
Spike
protein.
Together,
these
results
demonstrate
our
may
be
promising
nasal
vaccine
candidate
for
boosting
immunity
future
VOCs.